The overall decline may be attributed to a number of factors, including the closure of two large funders (The Irene Diamond Fund and The Diana, Princess of Wales Memorial Fund), at least five funders closing or reducing their HIV-specific portfolios, and several major pharmaceutical companies shifting some funding to other health areas such as Hepatitis C, chronic diseases and maternal and child health. Overall the field continues to remain strongly influenced by the world’s largest philanthropic funder of HIV, the Bill & Melinda Gates Foundation, which represented more than a third of all funding and decreased grantmaking to HIV by $11 million from 2012 to 2013.

Through this resource tracking effort, FCAA has been monitoring the field of HIV/AIDS philanthropy for more than a decade. This report intends to inform stakeholders about the overall distribution and trends of global AIDS philanthropy. the financial data is largely sourced from surveys completed by funders, with supplemental review of grants databases and funders' grants lists. Data was obtained for over 200 organizations that are believed to represent the substantial majority of global HIV/AIDS philanthropy.

View the report

This report is available as a downloadable PDF or readable in an interactive, online flash viewer (click on report below to open).

FCAA Resource Tracking Project Launch

FCAA requests your participation in the
annual HIV/AIDS resource tracking project. Please
join us in participation, to help demonstrate the true impact of the sector's
response and ensure that every grant to HIV/AIDS is counted.

This year, we ask that funders simply send a list of HIV/AIDS-related grants,
with grant descriptions, for calendar year 2014. Grant lists should include the
following categories for each grant:

·Granteename (can be withheld if this
information is sensitive)

·Amount
disbursed in 2014 (and currency if not USD)

·Grantee country/
U.S. state (geographic end-recipient of funding)

·Grant description
(Ideally, providing enough information for us to determine intended use, target
population, and general strategy. See taxonomy for more details.)